Intracranial hypertension in a patient using topical adapalene

Journal of Neuro-Ophthalmology

Volumn 28, Issue 2, 2008, Pages 156-158

  Givre, Syndee J ^a   Fleischman, David ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; DERMATOLOGICAL AGENT; NAPHTHALENE DERIVATIVE;

ACNE; ADULT; CASE REPORT; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEADACHE; HUMAN; INTRACRANIAL HYPERTENSION; LETTER; OBESITY; PAPILLEDEMA; PERIMETRY; PRIORITY JOURNAL; ACNE VULGARIS; BRAIN ARTERY; BRAIN PSEUDOTUMOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADULT; CEREBRAL ARTERIES; DERMATOLOGIC AGENTS; FEMALE; HEADACHE; HUMANS; MAGNETIC RESONANCE IMAGING; NAPHTHALENES; PAPILLEDEMA; PSEUDOTUMOR CEREBRI;

EID: 52049118604     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNO.0b013e318175c9da     Document Type: Letter

References (5)

1. Jacobson DM, Berg R, Wall M, et al. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology 1999;53: 1114-8.
2. Fraunfelder FW, Fraunfelder FT. Evidence for a probable causal relationship between tretinoin, acitretin, and etretinate and intracranial hypertension. J Neuro-ophthalmol 2004;24:214-6.
3. Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol 2005;6:29-37.
4. Shroot B, Michel S. Pharmacology and chemistry of adapalene. J Am Acad Dermatol 1997;36:S96-S103.
5. Bikowski JB. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. J Drugs Dermatol 2005;4:41-7.